NHS National Pharmaceuticals Transition 2021_3

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
04 Nov 2021
Delivery
not specified
Deadline
n/a

Related Terms

Location

United Kingdom: Please refer to Document 3, Schedule 8 in the ITO Documents for the list of purchasing points

Geochart for 1 buyers and 59 suppliers

1 buyer

36 suppliers

Description

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633

Lot Division

1 Hospital Only Products – CESW region

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products:LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition:LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)
2 Hospital Only Products – LSNE region

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
3 Hospital Only Products – NWLN region

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)
4 Oral (plus non-parenteral) products: All regions

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)
5 Transition Products – CESW region

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)
6 Transition Products – LSNE region

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)
7 Transition Products – NWLN region

NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)

Award Detail

1 Glenmark Pharmaceuticals Europe (Watford)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-1
  • Value: £1
2 Zentiva Pharma (Guildford)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-2
  • Value: £1
3 Drreddys Laboratories (Beverley)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-3
  • Value: £1
4 Brown & Burk (Uxbridge)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-4
  • Value: £1
5 Thornton & Ross (Huddersfield)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-5
  • Value: £1
6 Medac Pharma (Stirling)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-6
  • Value: £1
7 Kensington Pharma (Preston)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-7
  • Value: £1
8 Mylan (Hatfield)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-8
  • Value: £1
9 Morningside Pharmaeuticals (Loughborough)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-9
  • Value: £1
10 Torbay Pharmaceuticals (Paignton)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-10
  • Value: £1
11 Ranbaxy (Hayes)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-11
  • Value: £1
12 Aspire Pharma (Petersfield)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-12
  • Value: £1
13 Kent Pharma (Ashford)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-13
  • Value: £1
14 Pfizer (Tadworth)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-14
  • Value: £1
15 Panpharma (Liverpool)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-15
  • Value: £1
16 Teva (Castleford)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-16
  • Value: £1
17 Drugsrus (Harrow)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-17
  • Value: £1
18 Alturix (Milton Keynes)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-18
  • Value: £1
19 Colonis Pharma (Weybridge)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-19
  • Value: £1
20 Ambe Medical Group (Edenbridge)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-20
  • Value: £1
21 Aspen Pharmacare (Maidenhead)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-21
  • Value: £1
22 CST Pharma (Walsall)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-22
  • Value: £1
23 Macure Pharma Aps (Copenhagen)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-23
  • Value: £1
24 Accord (Barnstaple)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-24
  • Value: £1
25 Lucane Pharma (Ankeveen)
  • Hospital Only Products – CESW region
  • Reference: 027695-2021-25
  • Value: £1
26 Mercury Pharmaceuticals (London)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-26
  • Value: £1
27 Wockhardt (Wrexham)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-27
  • Value: £1
28 Aguettant (Bristol)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-28
  • Value: £1
29 Roche Products (Welwyn Garden City)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-29
  • Value: £1
30 Teva (Castleford)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-30
  • Value: £1
31 Drugsrus (Harrow)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-31
  • Value: £1
32 Colonis Pharma (Weybridge)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-32
  • Value: £1
33 Macure Pharma Aps (Copenhagen)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-33
  • Value: £1
34 Accord (Barnstaple)
  • Hospital Only Products – LSNE region
  • Reference: 027695-2021-34
  • Value: £1
35 Seacross Pharmaceuticals (London)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-35
  • Value: £1
36 Laboratorio Reig Jofre (Bideford)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-36
  • Value: £1
37 Consilient Health (Richmond upon Thames)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-37
  • Value: £1
38 Drugsrus (Harrow)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-38
  • Value: £1
39 Alturix (Milton Keynes)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-39
  • Value: £1
40 Colonis Pharma (Weybridge)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-40
  • Value: £1
41 Macure Pharma Aps (Copenhagen)
  • Hospital Only Products – NWLN region
  • Reference: 027695-2021-41
  • Value: £1
42 Glenmark Pharmaceuticals Europe (Watford)
  • Oral (plus non-parenteral) products: All regions
  • Reference: 027695-2021-42
  • Value: £1
43 Day Lewis Medical (Croydon)
  • Oral (plus non-parenteral) products: All regions
  • Reference: 027695-2021-43
  • Value: £1
44 Napp Pharmaceuticals (Cambridge)
  • Oral (plus non-parenteral) products: All regions
  • Reference: 027695-2021-44
  • Value: £1
45 Cipla Eu (London)
  • Oral (plus non-parenteral) products: All regions
  • Reference: 027695-2021-45
  • Value: £1
46 Mylan (Hatfield)
  • Oral (plus non-parenteral) products: All regions
  • Reference: 027695-2021-46
  • Value: £1
47 Teva (Castleford)
  • Oral (plus non-parenteral) products: All regions
  • Reference: 027695-2021-47
  • Value: £1
48 Amarox (Harrow)
  • Transition Products – LSNE region
  • Reference: 027695-2021-48
  • Value: £1
49 Teva (Castleford)
  • Transition Products – LSNE region
  • Reference: 027695-2021-49
  • Value: £1
50 Drreddys Laboratories (Beverley)
  • Transition Products – CESW region
  • Reference: 027695-2021-50
  • Value: £1
51 Cipla Eu (London)
  • Transition Products – CESW region
  • Reference: 027695-2021-51
  • Value: £1
52 Mylan (Hatfield)
  • Transition Products – CESW region
  • Reference: 027695-2021-52
  • Value: £1
53 Amarox (Harrow)
  • Transition Products – CESW region
  • Reference: 027695-2021-53
  • Value: £1
54 Teva (Castleford)
  • Transition Products – CESW region
  • Reference: 027695-2021-54
  • Value: £1
55 Accord (Barnstaple)
  • Transition Products – CESW region
  • Reference: 027695-2021-55
  • Value: £1
56 Thornton & Ross (Huddersfield)
  • Transition Products – NWLN region
  • Reference: 027695-2021-56
  • Value: £1
57 Cipla Eu (London)
  • Transition Products – NWLN region
  • Reference: 027695-2021-57
  • Value: £1
58 Amarox (Harrow)
  • Transition Products – NWLN region
  • Reference: 027695-2021-58
  • Value: £1
59 Teva (Castleford)
  • Transition Products – NWLN region
  • Reference: 027695-2021-59
  • Value: £1

Renewal Options

option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-02b7a6
  • FTS 027695-2021

Domains